---
schema_version: "secwatch.filing_event.v1"
accession: "0001823239-25-000105"
form_type: "8-K"
ticker: "MRVI"
cik: "0001823239"
company_name: "MARAVAI LIFESCIENCES HOLDINGS, INC."
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:40:05.568969+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Maravai Q2 revenue down 32% to $47.4M; net loss $69.8M; restructuring cuts 25% of workforce

## Summary
- Q2 revenue $47.4M (-32% YoY); net loss $69.8M (incl. $30.4M goodwill impairment); adjusted EBITDA -$10.4M vs +$13.0M.
- Announced restructuring targeting >$50M annualized savings; workforce reduction of ~25% with $8-9M severance costs.
- Withdrew 2025 revenue guidance pending new leadership's business review.
- CEO Bernd Brust recently appointed; EVP CCO Rebecca Buzzeo and EVP CAO Pete Leddy departing.
- Base business revenue (ex high-volume CleanCap) grew 5% YoY; positive free cash flow expected by H2 2026.

## SEC filing metadata
- accession: 0001823239-25-000105
- form_type: 8-K
- ticker: MRVI
- cik: 0001823239
- company_name: MARAVAI LIFESCIENCES HOLDINGS, INC.
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 2.05, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000105/0001823239-25-000105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000105/mrvi-20250807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001823239-25-000105
- JSON: https://secwatch.observer/filing/0001823239-25-000105.json
- Plain text: https://secwatch.observer/filing/0001823239-25-000105.txt

## Key facts
- Restructurings & Charges
  MARAVAI LIFESCIENCES HOLDINGS, INC. announced a restructuring with charges of $8.0 million to $9.0 million affecting the Company's workforce (approximately 25% of the Company's workforce).
  - Type: restructuring
  - Charge: $8.0 million to $9.0 million
  - Affected area: the Company's workforce
  - Headcount: approximately 25% of the Company's workforce
  source text: On August 11, 2025, the Company announced an organizational restructuring, including a workforce reduction, to reduce operating costs. The workforce reduction, which is being implemented as part of a strategic cost-reduction initiative, was committed to by management on August 8, 2025 and is expected to impact approximately 25% of the Company’s workforce. In connection with the workforce reduction, the Company currently estimates it will incur restructuring and related costs in the range of $8.0 million to $9.0 million, consisting primarily of employee severance and benefits costs, the majority of which the Company expects to recognize in the second half of 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000105/0001823239-25-000105-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.